Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Return on Equity (2020 - 2025)

Biodesix's Return on Equity history spans 6 years, with the latest figure at 17.0% for Q4 2025.

  • For Q4 2025, Return on Equity rose 1875.0% year-over-year to 17.0%; the TTM value through Dec 2025 reached 17.0%, up 1875.0%, while the annual FY2025 figure was 3.87%, 51.0% down from the prior year.
  • Return on Equity reached 17.0% in Q4 2025 per BDSX's latest filing, down from 136.86% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 136.86% in Q3 2025 to a low of 32.47% in Q4 2023.
  • Average Return on Equity over 5 years is 10.9%, with a median of 2.13% recorded in 2025.
  • The largest YoY upside for Return on Equity was 13822bps in 2025 against a maximum downside of -10156bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 2.54% in 2021, then crashed by -161bps to 6.63% in 2022, then tumbled by -390bps to 32.47% in 2023, then skyrocketed by 95bps to 1.75% in 2024, then surged by 1069bps to 17.0% in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Return on Equity are 17.0% (Q4 2025), 136.86% (Q3 2025), and 6.8% (Q2 2025).